![Insights from 2023 ASCO® Annual Meeting](http://media.vumedi.com/thumbs/channel_logo/2023/5/a2df459d-f523-49c6-86db-fbc880f4b695.png.200x0_q85.png)
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Subgroup Analysis of the RIGHT Choice Trial - Outcomes With 1L Ribociclib + ET vs. Physician’s Choice Combination Chemo by Age in Pre/Perimenopausal Pts With Aggressive HR+/HER2- aBC"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Nagi El Saghir
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Nagi El Saghir
273 views
June 9, 2023
Comments 0
Login to view comments.
Click here to Login
Breast